Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Vlatka Periša

33943

Vlatka

Periša

doc. dr. sc.

Naziv Uloga Akcije
Integrirani modeli kroničnih bolesti suradnik
NGS analiza raznolikosti TCRβ repertoara perifernih TCRVα7.2+MR1+ MAIT stanica u oboljelih od vulgarne psorijaze suradnik
Imunotranskriptom perifernih MR1+TCRVα7.2+ limfocita u vulgarnoj psorijazi: RNASeq analiza suradnik
Smanjena psihološka otpornost na stres (resilience) i kronične bolesti starenja suradnik
Prognostički čimbenici i radiografska kvantifikacija plućnih promjena kod koronavirusne bolesti 2019 (COVID-19) voditelj
Naziv Akcije
Krečak, Ivan ; Zekanović, Ivan ; Morić Perić, Martina ; Holik, Hrvoje ; Coha, Božena ; Periša, Vlatka ; Lucijanić, Marko High plateletcrit may be associated with thrombotic risk in polycythemia vera // International journal of laboratory hematology, (2023), doi: 10.1111/ijlh.14073
Lucijanić, Marko ; Krečak, Ivan ; Sorić, Ena ; Galušić, Davor ; Holik, Hrvoje ; Periša, Vlatka ; Morić Perić, Martina ; Zekanović, Ivan ; Kušec, Rajko Palpable spleen size is differently prognostic in primary and secondary myelofibrosis // Leukemia & lymphoma, 64 (2023), 4; 893-896. doi: 10.1080/10428194.2023.2179360
Krečak, Ivan ; Grohovac, Dragana ; Vučenović Bašić, Nikolina ; Čeko, Monika ; Nižetić, Karla ; Sabljić, Anica ; Holik, Hrvoje ; Galušić, Davor ; Zekanović, Ivan ; Morić Perić, Martina et al. Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms // Thrombosis research, (2023), doi: 10.1016/j.thromres.2023.03.004
(KroHem) Mitrović, Zdravko ; Dujmović, Dino ; Jakšić, Ozren ; Bašić-Kinda, Sandra ; Gaćina, Petar ; Periša, Vlatka ; Prka, Željko ; Dreta, Barbara ; Galušić Davor ; Holik, Hrvoje et al. Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem) // European journal of haematology, 111 (2023), 13957, 7. doi: 10.1111/ejh.13957
Jirouš Drulak, Maja; Grgić, Zvonimir; Plužarić, Vera; Šola, Marija; Opačak-Bernardi, Teuta; Viljetić, Barbara; Glavaš, Kristina; Tolušić-Levak, Maja; Periša, Vlatka; Mihalj, Martina et al. Characterization of the TCRβ repertoire of peripheral MR1-restricted MAIT cells in psoriasis vulgaris patients // Scientific reports, 13 (2023), 13; 20990, 14. doi: https://doi.org/10.1038/s41598-023-48321-z
Lucijanic, Marko ; Krecak, Ivan ; Soric, Ena ; Sabljic, Anica ; Galusic, Davor ; Holik, Hrvoje ; Perisa, Vlatka ; Peric, Martina Moric ; Zekanovic, Ivan ; Kusec, Rajko Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis // Biochemia medica, 33 (2023), 2; 020901, 8. doi: 10.11613/bm.2023.020901
Wittlinger, Thomas ; Bekić, Sanja ; Guljaš, Silva ; Periša, Vlatka ; Volarić, Mile ; Trtica Majnarić, Ljiljana Patterns of the physical, cognitive, and mental health status of older individuals in a real-life primary care setting and differences in coping styles // Frontiers in medicine, 9 (2022), 989814, 20. doi: 10.3389/fmed.2022.989814
Lucijanić, Marko ; Krečak, Ivan ; Sorić, Ena ; Sabljić, Anica ; Galušić, Davor ; Holik, Hrvoje ; Periša, Vlatka ; Morić Perić, Martina ; Zekanović, Ivan ; Kušec, Rajko Estimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks // Clinical Lymphoma Myeloma & Leukemia. 2022. str. S341-S342 doi: 10.1016/s2152-2650(22)01467-7
Krivdić Dupan, Zdravka ; Guljaš, Silva ; Periša, Vlatka ; Laslo, Dorian ; Salha, Tamer, Koruga, Nenad Hereditary hemorrhagic telangiectasia with bilateral pulmonary vascular malformations and a cerebral abscess as a complication: A case report // International journal of case reports and images, 8 (2022), 2; 4-8. doi: 10.5348/100105Z12ZD2022CR
Lucijanić, Marko ; Krečak, Ivan ; Sorić, Ena ; Sabljić, Anica ; Galušić, Davor ; Holik, Hrvoje ; Periša, Vlatka ; Morić Perić, Martina ; Zekanović, Ivan ; Kušec, Rajko Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis // Leukemia research, 119 (2022), 106905, 4. doi: 10.1016/j.leukres.2022.106905
nije evidentirano
nije evidentirano